BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 9568100)

  • 1. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
    Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
    Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical structure and tumor type specificity of "half-mustard type" phenothiazines.
    Motohashi N; Kurihara T; Sakagami H; Szabo D; Csuri K; Molnár J
    Anticancer Res; 1999; 19(3A):1859-64. PubMed ID: 10470128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of phenothiazine-related compounds.
    Nagy S; Argyelan G; Molnár J; Kawase M; Motohashi N
    Anticancer Res; 1996; 16(4A):1915-8. PubMed ID: 8712720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
    Hu K; Yao X
    Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytotoxicity of methyl protoneodioscin (NSC-698791) against human cancer cell lines in vitro.
    Hu K; Yao XS
    Anticancer Res; 2002; 22(2A):1001-5. PubMed ID: 12014616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
    Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
    Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
    Ford JM; Prozialeck WC; Hait WN
    Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
    Hu K; Yao X
    Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines.
    Efferth T; Sauerbrey A; Halatsch ME; Ross DD; Gebhart E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):56-67. PubMed ID: 12616342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
    Motohashi N; Sakagami H; Kamata K; Yamamoto Y
    Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
    Marx KA; O'Neil P; Hoffman P; Ujwal ML
    J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activity of newly synthesized azaphenothiazines from NCI's anticancer screening bank.
    Pluta K; Jeleń M; Morak-Młodawska B; Zimecki M; Artym J; Kocieba M
    Pharmacol Rep; 2010; 62(2):319-32. PubMed ID: 20508288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents.
    Katritzky AR; Girgis AS; Slavov S; Tala SR; Stoyanova-Slavova I
    Eur J Med Chem; 2010 Nov; 45(11):5183-99. PubMed ID: 20843586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
    Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
    J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
    Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
    J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-fluoro N(10)-substituted acridones and their cytotoxicity studies in sensitive and resistant cancer cell lines and their DNA intercalation studies.
    Mayur YC; ; Peters GJ; Lemos C; Kathmann I; Prasad VV
    Arch Pharm (Weinheim); 2009 Nov; 342(11):640-50. PubMed ID: 19856333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronic structure and cytotoxic activity of "half-mustard type" phenothiazines by MM3 and PM3 methods.
    Kurihara T; Nojima K; Sakagami H; Motohashi N; Molnár J
    Anticancer Res; 1999; 19(5B):3895-9. PubMed ID: 10628328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.